- posted: Mar. 12, 2021
- Medicaid
Zantac (Ranitidine) was a popular over-the-counter remedy for conditions like heartburn, stomach ache, acid reflux, and other common digestive ailments. Unfortunately, Zantac and its general products contain a contaminant called N-Nitrosodimehtylamine linked to several cancers.
The FDA requested its removal from the market on April 1, 2020, when it confirmed the carcinogen levels were higher than what is safe for consumption.
If you or a loved one faces a cancer diagnosis after using Zantac products, our attorneys can help. Contact us today.